Cargando…

Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma

SIMPLE SUMMARY: Soluble and exosomal programed death-ligand 1 can be upregulated in extranodal natural killer/T-cell lymphoma. We investigated the association between pre-treatment soluble and exosomal programed death-ligand 1 and outcomes in extranodal natural killer/T-cell lymphoma patients who re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seok Jin, Ryu, Kyung Ju, Park, Bon, Yoon, Sang Eun, Cho, Junhun, Park, Yoon, Kim, Won Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688922/ https://www.ncbi.nlm.nih.gov/pubmed/36428710 http://dx.doi.org/10.3390/cancers14225618

Ejemplares similares

EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma
por: Lee, Ji Yun, et al.
Publicado: (2021)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Simultaneous intraocular and cutaneous extranodal NK/T‐cell lymphoma refractory to multiple therapies including pembrolizumab
por: Mallal, Peter, et al.
Publicado: (2021)

Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma
por: Ryu, Kyung Ju, et al.
Publicado: (2020)

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review
por: Kim, Seok Jin, et al.
Publicado: (2018)

Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
por: Bang, Yeong Hak, et al.
Publicado: (2022)

Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
por: Kim, Hee Kyung, et al.
Publicado: (2015)

An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct
por: Ito, Hiroyuki, et al.
Publicado: (2019)

The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
por: Kim, Seok Jin, et al.
Publicado: (2015)

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma
por: Cho, Inju, et al.
Publicado: (2020)

Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
por: Kim, Seok Jin, et al.
Publicado: (2015)

The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma
por: Kim, Hyunsung, et al.
Publicado: (2022)

Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma
por: Ha, Joo Young, et al.
Publicado: (2020)

Extranodal NK/T-Cell Lymphoma Mimicking an Infectious Granuloma
por: Suh, Min Song, et al.
Publicado: (2019)

Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
por: Lee, Seungbok, et al.
Publicado: (2015)

Laryngeal recurrence of extranodal NK/T cell lymphoma
por: Kumai, Takumi, et al.
Publicado: (2021)

Leukemic presentation of extranodal NK/T‐cell lymphoma
por: Hafeez, Safina, et al.
Publicado: (2021)

Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report
por: Li, Lin-Jie, et al.
Publicado: (2022)

High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients
por: Wang, Hua, et al.
Publicado: (2016)

Extranodal NK/T-cell Lymphoma Mimicking Erythema Multiforme
por: Xia, Ying, et al.
Publicado: (2015)

Extranodal NK/T Cell Lymphoma Causing Cardiorespiratory Failure
por: Li, Yiting, et al.
Publicado: (2016)

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma
por: Hu, Boyu, et al.
Publicado: (2018)

Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis
por: Kawaguchi, Norihiko, et al.
Publicado: (2018)

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

Extranodal NK/T Cell Lymphoma Mimicking Behçet's Syndrome
por: Wang, Youyang, et al.
Publicado: (2021)

Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
por: Major, Ajay, et al.
Publicado: (2023)

Extranodal NK-T-Cell Lymphoma, Nasal-Type Misdiagnosed as Erythema Multiforme with Nasal Fungal Infection
por: Jeong, Soo Hyun, et al.
Publicado: (2022)

Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement
por: Lepeak, Lisa M., et al.
Publicado: (2011)

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
por: Wu, Ting, et al.
Publicado: (2015)

Multifocal primary cutaneous extranodal NK/T lymphoma nasal type
por: de Vasconcelos, Pedro, et al.
Publicado: (2016)

Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Jia, Yue, et al.
Publicado: (2019)

New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma
por: Yi, Wu, et al.
Publicado: (2022)

Treatment of extranodal NK/T-cell lymphoma: From past to future
por: Yan, Zheng, et al.
Publicado: (2023)

Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Tissue Type Involving the Dura
por: Choi, Joon Young, et al.
Publicado: (2016)

Predicting treatment response of patients with extranodal natural killer/T‐cell lymphoma based on levels of PD‐L1 mRNA and soluble PD‐L1
por: Feng, Yu, et al.
Publicado: (2020)

Recurrent Extranodal NK/T-Cell Lymphoma Presenting as a Perforating Palatal Ulcer and Oro-Nasal Fistula
por: Park, Kang Gyun, et al.
Publicado: (2016)

Prognostic value of single‐nucleotide polymorphisms for extranodal natural killer/T‐cell lymphoma: the identification of risk factors in the molecular era
por: Yoon, Sang Eun, et al.
Publicado: (2021)

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
por: Li, Xin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i2risnql4nqo0jg40brbaghgm4